Pharmasimple SA
PAR:ALPHS
Pharmasimple SA
PAR:ALPHS
Price:
0.0129
EUR
Market Closed
Market Cap:
€124.5k
Balance Sheet
Balance Sheet Decomposition
Pharmasimple SA
Pharmasimple SA
Balance Sheet Decomposition is not available for
Pharmasimple SA
Pharmasimple SA
Balance Sheet
Pharmasimple SA
Pharmasimple SA
Currency: EUR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
4
|
2
|
4
|
4
|
|
| Cash Equivalents |
0
|
1
|
1
|
4
|
2
|
4
|
4
|
|
| Total Receivables |
0
|
1
|
2
|
3
|
1
|
2
|
6
|
|
| Accounts Receivables |
0
|
1
|
2
|
2
|
1
|
1
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Inventory |
1
|
1
|
2
|
4
|
3
|
5
|
5
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
3
|
5
|
10
|
7
|
11
|
14
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
2
|
9
|
8
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
4
+97%
|
6
+43%
|
12
+111%
|
11
-12%
|
21
+104%
|
23
+9%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
2
|
3
|
5
|
4
|
5
|
8
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
1
|
2
|
3
|
2
|
3
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Liabilities |
1
|
2
|
4
|
7
|
7
|
9
|
13
|
|
| Long-Term Debt |
0
|
1
|
0
|
0
|
0
|
4
|
4
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
1
N/A
|
3
+134%
|
5
+49%
|
8
+53%
|
9
+13%
|
15
+67%
|
18
+23%
|
|
| Equity | ||||||||
| Common Stock |
1
|
1
|
2
|
7
|
7
|
8
|
8
|
|
| Retained Earnings |
0
|
0
|
1
|
3
|
5
|
3
|
5
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
1
+1%
|
1
+10%
|
4
+580%
|
2
-57%
|
7
+282%
|
5
-21%
|
|
| Total Liabilities & Equity |
2
N/A
|
4
+97%
|
6
+43%
|
12
+111%
|
11
-12%
|
21
+104%
|
23
+9%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
